Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026Business Wire • 02/05/26
Revvity Stock Up as Q4 Earnings Beat, Revenues In Line With EstimatesZacks Investment Research • 02/02/26
Revvity (RVTY) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 02/02/26
Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarterReuters • 02/02/26
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2025Business Wire • 02/02/26
Will Revvity Q4 Earnings Benefit From Early Signs of Demand Recovery?Zacks Investment Research • 01/29/26
Curious about Revvity (RVTY) Q4 Performance? Explore Wall Street Estimates for Key MetricsZacks Investment Research • 01/28/26
Artisan Mid Cap Value Fund Q4 2025 Performance Discussion And Portfolio ActivitySeeking Alpha • 01/21/26
Revvity, Inc. (RVTY) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial PerformanceBusiness Wire • 01/12/26
RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery ModelsZacks Investment Research • 01/12/26
Revvity Advances AI-Driven Scientific Discovery With Signals XyntheticaZacks Investment Research • 12/19/25
Revvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials DiscoveryBusiness Wire • 12/16/25
Revvity, Inc. (RVTY) Presents at Citi Annual Global Healthcare Conference 2025 TranscriptSeeking Alpha • 12/02/25